½ÃÀ庸°í¼­
»óǰÄÚµå
1528978

¼¼°èÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼³Ä¡, ¾ç½Ä, À¯Çü ¹× ÃÖÁ¾ ¿ëµµº° - ¿¹Ãø(2024-2032³â)

Stroke Post Processing Software Market - By Installation (Desktop, Mobile Phones & Tablets), Modality (CT, MRI), Type (Ischemic Stroke, Hemorrhagic Stroke), End-use (Hospitals & Clinics, Specialty Centers) - Global Forecast (2024 - 2032)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ³úÁ¹Áß ÈÄó¸® ¼Ò ÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â AI¿Í ¸Ó½Å·¯´× ±â¼ú ÅëÇÕÀ» À§ÇÑ ÆÄÆ®³Ê½Ê Áõ°¡·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 8.4%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°øµ¿¿¬±¸´Â AI ¾Ë°í¸®ÁòÀ» Ȱ¿ëÇÏ¿© ÀÇ·á ¿µ»ó µ¥ÀÌÅ͸¦ º¸´Ù Á¤È®Çϰí È¿À²ÀûÀ¸·Î ºÐ¼®ÇÔÀ¸·Î½á ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀ» °­È­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

°³¹ßÀÚµéÀº Áö¼ÓÀûÀ¸·Î ÷´Ü ±â¼úÀ» ÅëÇÕÇÏ¿© ³úÁ¹Áß È¯ÀÚÀÇ Áø´Ü Á¤È®µµ¿Í Ä¡·á °èȹÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº Á¤¹ÐÇÑ ÀÇ·á ¿µ»ó ºÐ¼®À» ±â¹ÝÀ¸·Î º¸´Ù °³ÀÎÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ³úÁ¹Áß Ä¡·á¸¦ ´õ¿í Çõ½ÅÀûÀ¸·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 11¿ù Visionable°ú Brainomix´Â ³úÁ¹Áß Ä¡·á Á¦°øÀ» °­È­Çϱâ À§ÇÑ Àü·«Àû Á¦ÈÞ¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â VisionableÀÇ °¡»ó ÇコÄɾî Ç÷§Æû°ú BrainomixÀÇ e-Stroke AI ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇÕÇÏ¿© ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î¸¦ ÃÖÀûÈ­ÇÏ¿© ±Þ¼º±â ÀÌÀüºÎÅÍ º´¿ø ³» Ä¡·á±îÁö °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

½ÃÀåÀº ¼³Ä¡, ¾ç½Ä, À¯Çü, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

¼³Ä¡¿Í °ü·ÃÇÏ¿©, ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î »ê¾÷¿¡¼­ ÈÞ´ëÆù ¹× ÅÂºí¸´ ´Ü¸»±â ºÐ¾ß´Â ÀÇ·á ¿µ»ó µ¥ÀÌÅÍÀÇ ¿ø°Ý ¾×¼¼½º ¹× ½Ç½Ã°£ ºÐ¼®¿¡ ÈûÀÔ¾î 2032³â±îÁö Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ»ç¿Í Àü¹®ÀǵéÀº Áø´Ü È¿À²¼º°ú ȯÀÚ Ä¡·á¸¦ °³¼±Çϱâ À§ÇØ ¸ð¹ÙÀÏ ±â±â¸¦ Ȱ¿ëÇÏ¿© ½ºÄµ À̹ÌÁö¸¦ ºü¸£°Ô ¿­¶÷Çϰí ÇØ¼®Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ßÀÚµéÀº AI¿Í ¸Ó½Å·¯´×À» Ȱ¿ëÇÏ¿© ºü¸£°í Á¤È®ÇÑ ºÐ¼®À» À§ÇØ ´õ¿í Á¤±³ÇÑ ¿ëµµ°ú ÀÎÅÍÆäÀ̽º¸¦ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î´Â Àü¹®¼¾ÅÍ ºÎ¹®ÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÌ 2024³âºÎÅÍ 2032³â±îÁö »ó½ÂÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àü¹®¼¾Å͵éÀº Á¤È®ÇÑ ÀÇ·á ¿µ»ó ºÐ¼®À» À§ÇÑ Ã·´Ü ±â¼úÀ» ÅëÇÕÇÏ¿© ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü¹® ¼ÒÇÁÆ®¿þ¾î¸¦ Ȱ¿ëÇØ Áø´Ü ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ°í ³úÁ¹Áß È¯ÀÚÀÇ Ä¡·á °èȹÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ³úÁ¹Áß Ä¡·áÀÇ Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃß°í, º¸´Ù Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ ºÐ¼®°ú °³ÀÎÈ­µÈ Ä¡·á Àü·«À» À§ÇÑ ¿¹Ãø ¸ðµ¨¸µÀ» ÅëÇÕÇÏ´Â ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀ» Çâ»ó½ÃÅ´À¸·Î½á ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î »ê¾÷ ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦´Â º¸´Ù Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á °èȹÀ» À§ÇÑ Ã·´Ü ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í·ÉÈ­ Àα¸ Áõ°¡´Â ÷´Ü ¿µ»ó ±â¼úÀ» Æ÷ÇÔÇÑ Çâ»óµÈ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ¿© Áö¿ª ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±â¼úÀû Àü¸Á
  • ±ÔÁ¦ »óȲ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¼³Ä¡º°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • µ¥½ºÅ©Åé
  • ÈÞ´ëÆù ¹× ÅÂºí¸´

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¸ð´Þ¸®Æ¼º°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • CT ½ºÄµ
  • MRI

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Çüº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÇãÇ÷¼º ³úÁ¹Áß
  • ÃâÇ÷¼º ³úÁ¹Áß
  • ±âŸ À¯Çü

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø ¹× Áø·á¼Ò
  • Àü¹®¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ±â¾÷ °³¿ä

  • Agfa-Gevaert NV
  • Aidoc
  • Avicenna.AI
  • Brainomix
  • Canon Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • icometrix
  • Koninklijke Philips N.V.
  • Nicolab B.V.
  • RapidAI
  • Siemens Healthineers AG
  • Subtle Medical, Inc.
  • SymphonyAI
  • Viz.ai, Inc.
LSH 24.08.20

Global Stroke Post Processing Software Market size will expand at 8.4% CAGR from 2024 to 2032, due to rising partnerships for integrating AI and machine learning technologies. Collaborations are helping to enhance software capabilities by leveraging AI algorithms to analyze medical imaging data more accurately and efficiently.

By continuously integrating advanced technologies, developers are improving diagnostic accuracy and treatment planning for stroke patients. This ongoing innovation is further transforming stroke care by providing more personalized and effective treatment solutions based on precise medical imaging analysis. For instance, in November 2022, Visionable and Brainomix announced a strategic partnership for enhancing stroke care delivery. This collaboration integrated Visionable's virtual healthcare platform with Brainomix's e-Stroke AI software to optimize the stroke post-processing software for improving care from pre-acute to intra-hospital stages.

The market is segregated into installation, modality, type, end-use, and region.

In terms of installation, the mobile phones & tablets segment in the stroke post processing software industry is set to experience growth at a significant rate through 2032 propelled by the remote access and real-time analysis of medical imaging data. Physicians and specialists are utilizing mobile devices to view and interpret scans promptly to enhance diagnostic efficiency and patient care. Additionally, developers are integrating more sophisticated applications and interfaces for leveraging AI and machine learning for rapid and accurate analysis.

By end-use, the stroke post processing software market from the specialty centers segment is projected to rise from 2024 to 2032. These centers are enhancing stroke post-processing software by integrating advanced technologies for precise medical imaging analysis. They are also leveraging specialized software to streamline diagnostic workflows and improve treatment planning for stroke patients. A rising focus on innovating stroke care and refining software capabilities to integrate more comprehensive data analytics and predictive modeling for personalized treatment strategies will favor segment growth.

Regionally, the Asia Pacific stroke post processing software industry size is projected to depict robust growth between 2024 and 2032, driven by regulatory support and guidelines to encourage the adoption of advanced medical technologies. These regulations are facilitating the integration of sophisticated software solutions for more accurate diagnosis and treatment planning. Additionally, the growing aging population is driving the demand for improved healthcare solutions including advanced imaging technologies, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of stroke globally
      • 3.2.1.2 Advancements in stroke post processing software
      • 3.2.1.3 Growing adoption of AI and machine learning
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of software
      • 3.2.2.2 Limited accessibility and training
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Installation, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Desktop
  • 5.3 Mobile phones & tablets

Chapter 6 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 CT scan
  • 6.3 MRI

Chapter 7 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Ischemic stroke
  • 7.3 Hemorrhagic stroke
  • 7.4 Other types

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals & clinics
  • 8.3 Specialty centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Agfa-Gevaert NV
  • 10.2 Aidoc
  • 10.3 Avicenna.AI
  • 10.4 Brainomix
  • 10.5 Canon Inc.
  • 10.6 F. Hoffmann-La Roche Ltd.
  • 10.7 GE HealthCare Technologies Inc.
  • 10.8 icometrix
  • 10.9 Koninklijke Philips N.V.
  • 10.10 Nicolab B.V.
  • 10.11 RapidAI
  • 10.12 Siemens Healthineers AG
  • 10.13 Subtle Medical, Inc.
  • 10.14 SymphonyAI
  • 10.15 Viz.ai, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦